Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice

Autor: Jiwang Chen, Ramaswamy Ramchandran, J. Usha Raj, Qiwei Yang, Miranda Sun
Rok vydání: 2016
Předmět:
0301 basic medicine
Vascular smooth muscle
medicine.medical_treatment
Clinical Biochemistry
Blood Pressure
Receptor
IGF Type 1

Pathogenesis
Insulin-like growth factor
Insulin-Like Growth Factor I
Hypoxia
Original Research
Mice
Knockout

Imidazoles
Up-Regulation
medicine.anatomical_structure
Organ Specificity
Pyrazines
medicine.symptom
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Systole
Hypertension
Pulmonary

Myocytes
Smooth Muscle

Pulmonary Artery
Vascular Remodeling
03 medical and health sciences
Right ventricular hypertrophy
Internal medicine
medicine
Animals
RNA
Messenger

Molecular Biology
Cell Proliferation
Lung
Hypertrophy
Right Ventricular

business.industry
Growth factor
Muscle
Smooth

Cell Biology
Hypoxia (medical)
medicine.disease
Pulmonary hypertension
Mice
Inbred C57BL

030104 developmental biology
Endocrinology
Animals
Newborn

Chronic Disease
business
Proto-Oncogene Proteins c-akt
Gene Deletion
Zdroj: American Journal of Respiratory Cell and Molecular Biology. 55:779-791
ISSN: 1535-4989
1044-1549
Popis: Insulin-like growth factor (IGF)-1 is a potent mitogen of vascular smooth muscle cells (SMCs), but its role in pulmonary vascular remodeling associated with pulmonary hypertension (PH) is not clear. In an earlier study, we implicated IGF-1 in the pathogenesis of hypoxia-induced PH in neonatal mice. In this study, we hypothesized that hypoxia-induced up-regulation of IGF-1 in vascular smooth muscle is directly responsible for pulmonary vascular remodeling and PH. We studied neonatal and adult mice with smooth muscle-specific deletion of IGF-1 and also used an inhibitor of IGF-1 receptor (IGF-1R), OSI-906, in neonatal mice. We found that, in neonatal mice, SMC-specific deletion of IGF-1 or IGF-1R inhibition with OSI-906 attenuated hypoxia-induced pulmonary vascular remodeling in small arteries, right ventricular hypertrophy, and right ventricular systolic pressure. Pulmonary arterial SMCs from IGF-1-deleted mice or after OSI-906 treatment exhibited reduced proliferative potential. However, in adult mice, smooth muscle-specific deletion of IGF-1 had no effect on hypoxia-induced PH. Our data suggest that vascular smooth muscle-derived IGF-1 plays a critical role in hypoxia-induced PH in neonatal mice but not in adult mice. We speculate that the IGF-1/IGF-1R axis is important in pathogenesis of PH in the developing lung and may be amenable to therapeutic manipulation in this age group.
Databáze: OpenAIRE